Warner NA - Search Results

1

Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.

Sha BE, D'Amico RD, Landay AL, Spear GT, Massad LS, Rydman RJ, Warner NA, Padnick J, Ackatz L, Charles LA, Benson CA. Sha BE, et al. Among authors: warner na. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):161-8. doi: 10.1097/00042560-199711010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9390567

2

Salivary immunoglobulin A antibodies to gp41 in human immunodeficiency virus-seropositive patients: lack of correlation with disease progression.

Toro MJ, Escalona L, Chaiyarit P, Warner NA, Gregory RL. Toro MJ, et al. Among authors: warner na. Oral Microbiol Immunol. 2001 Jun;16(3):188-92. doi: 10.1034/j.1399-302x.2001.016003188.x. Oral Microbiol Immunol. 2001. PMID: 11358543

3

Expression of MHC Class II, CD70, CD80, CD86 and pro-inflammatory cytokines is differentially regulated in oral epithelial cells following bacterial challenge.

Han DC, Huang GT, Lin LM, Warner NA, Gim JS, Jewett A. Han DC, et al. Among authors: warner na. Oral Microbiol Immunol. 2003 Dec;18(6):350-8. doi: 10.1046/j.0902-0055.2003.00094.x. Oral Microbiol Immunol. 2003. PMID: 14622340

4

Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.

Iser DM, Warner N, Revill PA, Solomon A, Wightman F, Saleh S, Crane M, Cameron PU, Bowden S, Nguyen T, Pereira CF, Desmond PV, Locarnini SA, Lewin SR. Iser DM, et al. J Virol. 2010 Jun;84(12):5860-7. doi: 10.1128/JVI.02594-09. Epub 2010 Mar 31. J Virol. 2010. PMID: 20357083 Free PMC article.

5

Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.

Locarnini S, Warner N. Locarnini S, et al. Antivir Ther. 2007;12 Suppl 3:H15-23. Antivir Ther. 2007. PMID: 18284179 Review.

6

The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes.

Wilson R, Warner N, Ryan K, Selleck L, Colledge D, Rodgers S, Li K, Revill P, Locarnini S. Wilson R, et al. J Viral Hepat. 2011 Oct;18(10):e499-507. doi: 10.1111/j.1365-2893.2011.01484.x. Epub 2011 Aug 18. J Viral Hepat. 2011. PMID: 21914069

7

A novel hepatitis B virus S gene insertion associated with reduced humoral immunity and diagnostic escape.

Flanagan E, Thompson AJ, Colledge D, Edwards R, Littlejohn M, Walsh R, Warner N, Bowden DS, Iser DM. Flanagan E, et al. Intern Med J. 2014 Jul;44(7):709-10. doi: 10.1111/imj.12465. Intern Med J. 2014. PMID: 25041776 No abstract available.

8

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.

Betz-Stablein BD, Töpfer A, Littlejohn M, Yuen L, Colledge D, Sozzi V, Angus P, Thompson A, Revill P, Beerenwinkel N, Warner N, Luciani F. Betz-Stablein BD, et al. J Virol. 2016 Jul 27;90(16):7171-7183. doi: 10.1128/JVI.00243-16. Print 2016 Aug 15. J Virol. 2016. PMID: 27252524 Free PMC article.

9

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound.

Warner N, Locarnini S. Warner N, et al. Hepatology. 2008 Jul;48(1):88-98. doi: 10.1002/hep.22295. Hepatology. 2008. PMID: 18537180

10

Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

Warner N, Locarnini S. Warner N, et al. Antivir Ther. 2009;14(2):139-42. Antivir Ther. 2009. PMID: 19430088 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters